Treating Multiple Sclerosis with Medical Marijuana
Medical Marijuana Awareness Post-Webinar Resources
The Webinar
Thank you to everyone who attended the July 23rd Medical Marijuana Awareness webinar on Multiple Sclerosis and Medical Marijuana!
Watch the video on our YouTube Channel! Your questions and comments during the live Q&A helped to make a great source of information for the next person seeking treatment.
Speakers featured in this webinar were host Marc Matoza and Andrew Burke of Trulieve.
Ongoing Education
Click an item from the index below to skip to that section.
Overview: What is Multiple Sclerosis?
- Medical Marijuana 101 Patient Education Packet
- MMTCFL Chronic Conditions Resources
- How Cannabis Works on the Human Body with Cannigma
Materials from the Webinar
- View the slides from the live presentation
- How CBD Oil Affects Chronic Pain and Inflammation with Thomas DeLauer
- Weed (Parts 1-4) with Dr. Sanjay Gupta
Cannachats Recommended Reading
- Multiple Sclerosis & Medical Marijuana
- Basics of Medical Marijuana in Florida
What is Multiple Sclerosis?
Overview by Medical Marijuana Treatment Clinics of Florida
Multiple Sclerosis, or MS, is a process involving the immune system where an abnormal response by the immune system of the body is directed against the nervous system. The central nervous system, which is most impacted by MS, consists of one’s brain, spinal cord, and optic nerves. The abnormal response by the immune system leads to inflammation that damages the system’s myelin, the nerve fibers, and the cells which produce myelin.
See Also:
How Cannabis Works on the Human Body
Endocannabinoid receptors have been discovered in various parts of the peripheral and central nervous system, and in almost every aspect of the pain pathway. Other endocannabinoid receptors have been found to play a role in reducing and regulating inflammatory pain.”
Materials from the Webinar
How CBD Oil Affects Chronic Pain and Inflammation
Weed (Parts 1-3)
Weed (Part 4)
Cannachats Recommended Reading
Multiple Sclerosis & Medical Marijuana
Barnes, M. (2006). Expert Opin Pharmacother , 607 15.
Backes, M. Weil, A. McCue, J.D.
Consroe, P.e. (1997). European Neurology , 44 48.
Kurt D. Ackerman, M. e. (2002). Psychosomatic Medicine , 916 20.
Michelle Cameron, MD, PT, MCR & Jessica Rice, MR. (n.d.). National Multiple Sclerosis Society.
Basics of Medical Marijuana in Florida
Medical Marijuana Awareness Webinars, in partnership with MMTCFL
Florida Department of Health | KnowtheFactsMMJ.com
Click to Download from the Office of Medical Marijuana Use
MarijuanaAware.com
suncoastnorml.org
Supplemental Research
Al Mansouri, Ojha S., Al Maamari, Al Ameri M, Nurulain, S.M., & Bahi, A. (2014).Pharmocology, Biochemistry and Behavior , 260 8.
Outlook, N. L. (2018, Aug 14).Retrieved from New Life Outlook: Multiple Sclerosis
Page, S. e. (2003). Can J Neurol Sci , 201 205.
tetrahydrocannabinol.
Petro, D. &. (1981). Journal of Clinical Pharmacology , 413 416.
Rufino AT, Ribeiro M, Judas F, et al. (2014). Journal of Natural Products
Sundqvist, E. e. (2010). Eur J Hum Genet , 1349 52.
Varda, M. T. M. (1970). Psychosomatic Medicine , 67 86.